Hepatitis Monthly

Published by: Kowsar

The Comparative Efficacy and Safety of Peginterferon Alpha-2a vs. 2b for the Treatment of Chronic HCV Infection: A Meta-Analysis

Seyed Moayed Alavian 1 , * , Bita Behnava 2 and Seyed Vahid Tabatabaei 2
Authors Information
1 Baqiyatallah Research Center for Gastroenterology and Liver Disease, editor@hepmon.com, Tehran, IR.Iran
2 Baqiyatallah Research Center for Gastroenterology and Liver Disease, Baqiyatallah University of Medical Sciences, Tehran, IR.Iran
Article information
  • Hepatitis Monthly: , 10 (2); 121-131
  • Article Type: Review Article
  • Received: February 8, 2010
  • Accepted: March 12, 2010

To Cite: Alavian S, Behnava B, Tabatabaei S. The Comparative Efficacy and Safety of Peginterferon Alpha-2a vs. 2b for the Treatment of Chronic HCV Infection: A Meta-Analysis, Hepat Mon. Online ahead of Print ;10(2):121-131.

Abstract
© 0, Hepatitis Monthly. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
Full Text
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments